Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$1.6B |
| 2 |
American Express
AXP
|
+$398M |
| 3 |
Capital One
COF
|
+$151M |
| 4 |
Apollo Global Management
APO
|
+$111M |
| 5 |
DFS
Discover Financial Services
DFS
|
+$109M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.16B |
| 2 |
Microsoft
MSFT
|
+$873M |
| 3 |
Amazon
AMZN
|
+$403M |
| 4 |
NVIDIA
NVDA
|
+$356M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$283M |
Sector Composition
| 1 | Technology | 30.21% |
| 2 | Healthcare | 13.75% |
| 3 | Consumer Discretionary | 12.04% |
| 4 | Industrials | 9.22% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
551
Neurocrine Biosciences
NBIX
$14.3B
| $33.2M | 0.02% |
352,200
-28,300
| -7% | -$2.67M |
|
552
Generac Holdings
GNRC
$10.8B
| $33.2M | 0.02% |
222,600
-28,600
| -11% | -$4.27M |
|
553
NIO
NIO
$13.9B
| $33.2M | 0.02% |
3,424,241
-351,976
| -9% | -$3.41M |
|
554
Fortune Brands Innovations
FBIN
$7.29B
| $33M | 0.02% |
458,500
-50,400
| -10% | -$3.63M |
|
555
A.O. Smith
AOS
$10.4B
| $32.9M | 0.02% |
451,500
-50,700
| -10% | -$3.69M |
|
556
Huntington Ingalls Industries
HII
$10.6B
| $32.7M | 0.02% |
143,600
-14,300
| -9% | -$3.25M |
|
557
Vistra
VST
$63.7B
| $32.4M | 0.02% |
1,234,273
-183,400
| -13% | -$4.81M |
|
558
Knight Transportation
KNX
$6.94B
| $32.3M | 0.02% |
581,396
-22,900
| -4% | -$1.27M |
|
559
Campbell Soup
CPB
$10.1B
| $32.1M | 0.02% |
702,900
-127,700
| -15% | -$5.84M |
|
560
F5
FFIV
$18.4B
| $31.8M | 0.02% |
217,200
-21,800
| -9% | -$3.19M |
|
561
NRG Energy
NRG
$28.6B
| $31.3M | 0.02% |
836,900
-75,100
| -8% | -$2.81M |
|
562
Cleveland-Cliffs
CLF
$5.45B
| $31.2M | 0.02% |
1,859,840
-185,100
| -9% | -$3.1M |
|
563
Jabil
JBL
$22.4B
| $31.2M | 0.02% |
288,800
-1,800
| -0.6% | -$194K |
|
564
American Financial Group
AFG
$11.5B
| $31.1M | 0.02% |
261,500
-25,000
| -9% | -$2.97M |
|
565
Boston Properties
BXP
$12B
| $30.9M | 0.02% |
535,800
-53,700
| -9% | -$3.09M |
|
566
Hasbro
HAS
$11.1B
| $30.8M | 0.02% |
475,400
-44,000
| -8% | -$2.85M |
|
567
Dentsply Sirona
XRAY
$2.83B
| $30.6M | 0.02% |
764,101
-88,700
| -10% | -$3.55M |
|
568
Lear
LEA
$6B
| $30.5M | 0.02% |
212,500
-21,400
| -9% | -$3.07M |
|
569
Bio-Rad Laboratories Class A
BIO
$7.86B
| $30.2M | 0.02% |
79,600
-8,600
| -10% | -$3.26M |
|
570
Teva Pharmaceuticals
TEVA
$22.1B
| $30M | 0.02% |
3,984,300
-417,100
| -9% | -$3.14M |
|
571
Arrow Electronics
ARW
$6.49B
| $29.7M | 0.02% |
207,100
-36,300
| -15% | -$5.2M |
|
572
Dick's Sporting Goods
DKS
$17.9B
| $29.6M | 0.02% |
224,100
+95,000
| +74% | +$12.6M |
|
573
Bath & Body Works
BBWI
$5.87B
| $29.4M | 0.02% |
784,800
-119,300
| -13% | -$4.47M |
|
574
Texas Pacific Land
TPL
$21B
| $29.4M | 0.02% |
66,951
-6,300
| -9% | -$2.76M |
|
575
Whirlpool
WHR
$5.34B
| $29.2M | 0.02% |
196,100
-19,600
| -9% | -$2.92M |
|